Back to Search Start Over

Kawasaki disease in adults: Observations in France and literature review.

Authors :
Fraison JB
Sève P
Dauphin C
Mahr A
Gomard-Mennesson E
Varron L
Pugnet G
Landron C
Roblot P
Oziol E
Chalhoub G
Galempoix JM
Humbert S
Humbert P
Sbidian E
Grange F
Bayrou O
Cathebras P
Morlat P
Epaulard O
Pavese P
Huong du LT
Zoulim A
Stankovic K
Bachelez H
Smail A
Bachmeyer C
Granel B
Serratrice J
Brinchault G
Mekinian A
Costedoat-Chalumeau N
Bourgarit-Durand A
Puéchal X
Guillevin L
Piram M
Koné-Paut I
Fain O
Source :
Autoimmunity reviews [Autoimmun Rev] 2016 Mar; Vol. 15 (3), pp. 242-9. Date of Electronic Publication: 2015 Nov 26.
Publication Year :
2016

Abstract

Objective: Kawasaki disease (KD) is a vasculitis that mostly occurs in young children and rarely in adults. We analyzed the characteristics of adult-onset KD (AKD) in France.<br />Methods: We collected retrospective and prospective data for patients with a diagnosis of KD occurring after the age of 18 years. Cases were obtained via various French medical networks and identified from the international literature.<br />Results: We included 43 patients of AKD at 26 institution from 1992 to 2015, with mean (SD) age 30 (11) years (range 18-68) and sex ratio (M/F) 1.2; 34 patients met the American Heart Association criteria and 9 were incomplete AKD. The median time to diagnosis was 13 days (interquartile range 8-21). The main symptoms were fever (100%), exanthema (98%), changes in the extremities (91%), conjunctivitis (77%), oral cavity changes (89%), cervical adenitis (55%) and cardiac abnormalities (45%). Overall, 35% of patients showed large-vessel vasculitis: coronary vasculitis (26%) and coronary aneurysm (19%). Treatment was mostly intravenous immunoglobulins (79%) and aspirin (81%). Four patients showed myocardial infarction due to coronary vasculitis, but none were treated with IVIg because of late diagnosis. After a median follow-up of 5 months (range 1-117), persistent aneurysm was noted in 9% of cases. Damage was significantly lower with early treatment than late or no treatment (p=0.01).<br />Conclusion: Given the high frequency of cardiac involvement and complications in this series of AKD, diagnosis and treatment should not be delayed, and early IVIg treatment seems to improve the outcome.<br /> (Copyright © 2015 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-0183
Volume :
15
Issue :
3
Database :
MEDLINE
Journal :
Autoimmunity reviews
Publication Type :
Academic Journal
Accession number :
26631821
Full Text :
https://doi.org/10.1016/j.autrev.2015.11.010